I underwent robot-assisted radical prostatectomy on March 23, 2026.
My final pathology was pT2 R1, Gleason 3+4 (Grade Group 2), with two positive left apical surgical margins measuring 4 mm and 1.2 mm, both containing only Gleason pattern 3.
There was no extraprostatic extension, seminal vesicle invasion, lymphovascular invasion, cribriform pattern, or intraductal carcinoma.
POSTOPERATIVE PSA RESULTS:
May 21, 2026 (7 weeks): 0.22 ng/mL
June 18, 2026 (11 weeks): 0.20 ng/mL
June 25, 2026 (13 weeks): 0.18 ng/mL (different laboratory)
September 23, 2026 (6 months): 0.22 ng/mL
I also underwent a 3T multiparametric MRI after surgery. The MRI showed no suspicious lesions or masses in the prostatectomy bed, no abnormal diffusion restriction or suspicious enhancement, and no suspicious pelvic lymph nodes.
Despite the positive surgical margins and persistently detectable PSA, the MRI showed no visible evidence of residual or recurrent cancer. However, I understand that microscopic disease cannot be ruled out, especially at such a low PSA level.
My PSA has remained essentially unchanged (0.22 → 0.20 → 0.22 at the same laboratory) over approximately four months.
My uro-oncologist recommended another PSA test in November 2026 and continued close monitoring if it remains stable.
Edited by member 14 Oct 2026 at 19:00
| Reason: Not specified